News Center

News details

The company is mainly engaged in the sales of raw materials, pharmaceutical intermediates and fine chemical products.

  • Categories:Company News
  • Author:
  • Origin:
  • Time of issue:2021-07-27
  • Views:0

(Summary description)The company was established in July 2019. The company is mainly engaged in the sales, research and development of APIs, pharmaceutical intermediates and fine chemical products, as well as technical consulting and testing services for new compounds. At present, the company has 300 square meters of research and development and testing laboratories, and is equipped with a variety of modern experimental research equipment, to meet the small-scale research and development of various compounds, new pharmaceuticals, chemical intermediates and customized synthesis services.

The company is mainly engaged in the sales of raw materials, pharmaceutical intermediates and fine chemical products.

(Summary description)The company was established in July 2019. The company is mainly engaged in the sales, research and development of APIs, pharmaceutical intermediates and fine chemical products, as well as technical consulting and testing services for new compounds. At present, the company has 300 square meters of research and development and testing laboratories, and is equipped with a variety of modern experimental research equipment, to meet the small-scale research and development of various compounds, new pharmaceuticals, chemical intermediates and customized synthesis services.

  • Categories:Company News
  • Author:
  • Origin:
  • Time of issue:2021-07-27
  • Views:0

The company was established in July 2019. The company is mainly engaged in the sales, research and development of APIs, pharmaceutical intermediates and fine chemical products, as well as technical consulting and testing services for new compounds. At present, the company has 300 square meters of research and development and testing laboratories, and is equipped with a variety of modern experimental research equipment, to meet the small-scale research and development of various compounds, new pharmaceuticals, chemical intermediates and customized synthesis services.

On

On September 26, 2021, the website of Wuhan Qingfeng Kaimo Biomedical Technology Co., Ltd. was officially launched.

On September 26, 2021, the website of Wuhan Qingfeng Kaimo Biomedical Technology Co., Ltd. was officially launched.
2021-09-23
Those

Those things that pharmaceutical intermediates R&D, production and management enterprises should know

In order to further strengthen the management and control of fentanyl substances and their precursors for pharmaceutical intermediates R&D, production and operation enterprises, and strictly prevent the occurrence of illegal and criminal activities in manufacturing, trafficking and smuggling, in accordance with relevant laws and policies, the relevant matters are hereby notified as follows:
2021-04-02
Search
Search

Wuhan Qingfeng Chemical Co.,ltd.

Address: Guanggu Avenue, East Lake New Technology Development Zone, Wuhan City, Hubei Province

Mobile: +8618672943286

E-mail: brian_zhao@whqfchem.com

© 2021  Wuhan Qingfeng Chemical Co.,ltd.  All rights reserved.   鄂ICP备2021010828号-1   Powered by www.300.cn

This website already supports IPv6 access

© 2021 Wuhan Qingfeng Chemical Co.,ltd. 

鄂ICP备2021010828号-1   Powered by www.300.cn